Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?
Publication/Presentation Date
3-1-2022
Abstract
Given the urgent need to control the spread of the novel COVID-19 virus, 13 vaccines have been approved for emergency use before completing all 3 phases of the clinical trials. Thereby a careful monitor of the adverse effects postvaccination is essential. We searched through PubMed and other reporting systems like VAERS for the reported cardiovascular adverse events post-COVID-19 vaccination. Through our review, we determined that the incidence of all the reported cardiovascular events is very rare. Additionally, the vaccine was initially given to the elderly and high-risk populations in which cardiovascular events such as myocardial infarction and arrhythmias are already more prevalent, while other cardiovascular events such as myocarditis or vaccine-induced thrombotic thrombocytopenia were more common in younger populations. Moreover, a direct causal relationship, if any, between vaccination and adverse events is yet to be fully elucidated. Thus, at this time point, the benefits of vaccination far outweigh the risk.
Volume
47
Issue
3
First Page
101077
Last Page
101077
ISSN
1535-6280
Published In/Presented At
Hana, D., Patel, K., Roman, S., Gattas, B., & Sofka, S. (2022). Clinical Cardiovascular Adverse Events Reported Post-COVID-19 Vaccination: Are They a Real Risk?. Current problems in cardiology, 47(3), 101077. https://doi.org/10.1016/j.cpcardiol.2021.101077
Disciplines
Medicine and Health Sciences
PubMedID
34902392
Department(s)
Hematology-Medical Oncology Division
Document Type
Article